Role of skeletal muscle in palate development

Histology and Histopathology

Volumn 28, Issue 1, 2013, Pages 1-13

  Rot, Irena ^a   Kablar, Boris ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Development; Epigenetics; Mouse; Palate; Skeletal muscle

Indexed keywords

ANIMAL; FETUS DEVELOPMENT; MOUSE; PALATE; PRENATAL DEVELOPMENT; REVIEW; SKELETAL MUSCLE;

ANIMALS; FETAL DEVELOPMENT; MICE; MUSCLE, SKELETAL; PALATE;

MAMMALIA; MUS;

EID: 84872195396     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Alappat S.R., Zhang Z., Suzuki K., Zhang X., Liu H., Jiang R., Yamada G. and Chen Y.P. (2005). The cellular and molecular etiology of the cleft secondary palate in Fgf10 mutant mice. Dev. Biol. 277, 102-113.
2. Allori A.C., Sailon A.M. and Warren S.M. (2008). Biological basis of bone formation, remodeling, and repair - Part I: Biochemical signaling molecules. Tissue Eng. Part B 14, 259-273.
3. Baguma-Nibasheka M. and Kablar B. (2009a). Abnormal retinal development in the Btrc null mouse. Dev. Dyn. 238, 2680-2687.
4. Baguma-Nibasheka M. and Kablar B. (2009b). Altered retinal cell differentiation in the AP-3 delta mutant (Mocha) mouse. Int. J. Dev. Neurosci. 27, 701-708.
5. -/- hypoplastic mouse lungs reveals a profile of genes involved in pneumocyte differentiation. Histol. Histopathol. 22, 483-495.
6. Baguma-Nibasheka M., Gugic D., Saraga-Babic M. and Kablar B. (2012). Role of skeletal muscle in lung development. Histol. Histopathol. 27, 817-826.
7. Barrow J.R. and Capecchi M.R. (1999). Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants. Development 126, 5011-5026.
8. Cai Y.Q., Cai G.Q., Liu G.X., Cai Q., Shi J.H., Shi J., Ma S.K., Sun X., Sheng Z.J., Mei Z.T., Cui D., Guo L., Wang Z. and Fei J. (2006). Mice with genetically altered GABA transporter subtype I (GAT1) expression show altered behavioral responses to ethanol. J. Neurosci. Res. 84, 255-267.
9. Carrasco D., Cheng J., Lewin A., Warr G., Yang H., Rizzo C., Rosas F., Snapper C. and Bravo R. (1998). Multiple hemopoietic defects and lymphoid hyperplasia in mice lacking the transcriptional activation domain of the c-Rel protein. J. Exp. Med. 187, 973-984.
10. Carvalho R.L., Itoh F., Goumans M.J., Lebrin F., Kato M., Takahashi S., Ema M., Itoh S., van Rooijen M., Bertolino P., Ten Dijke P. and Mummery C.L. (2007). Compensatory signaling induced in the yolk sac vasculature by deletion of TGF receptors in mice. J. Cell. Sci. 120, 4269-4277.
11. Chai Y. and Maxson R.E. (2006). Recent advances in craniofacial morphogenesis. Dev. Dyn. 235, 2353-2375.
12. Chytil A., Magnuson M.A., Wright C.V. and Moses H.L. (2002). Conditional inactivation of the TGF-beta type II receptor using Cre: Lox. Genesis 32, 73-75.
13. de Vries J.I. and Fong B.F. (2006). Normal fetal motility: an overview. Ultrasound Obstet. Gynecol. 27, 701-711.
14. Dode C., Levilliers J., Dupont J.M., De Paepe A., Le Du N., Soussi-Yanicostas N., Coimbra R.S., Delmaghani S., Compain-Nouaille S., Baverel F., Pecheux C., Le Tessier D., Cruaud C., Delpech M., Speleman F., Vermeulen S., Amalfitano A., Bachelot Y., Bouchard P., Cabrol S., Carel J.C., Delemarre-van de Waal H., Goulet-Salmon B., Kottler M.L., Richard O., Sanchez-Franco F., Saura R., Young J., Petit C. and Hardelin J.P. (2003). Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat. Genet. 33, 463-465.
15. Dudley A.T., Lyons K.M. and Robertson E.J. (1995). A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. 15, 2795-2807.
16. Eshkind L., Tian Q., Schmidt A., Franke W.W., Windoffer R. and Leube R.E. (2002). Loss of desmoglein 2 suggests essential functions for early embryonic development and proliferation of embryonal stem cells. Eur. J. Cell Biol. 81, 592-598.
17. Ferguson M.W.J. (1988). Palate development. Development 103, 41-60.
18. Francis-West P., Ladher R., Barlow A. and Graveson A. (1998). Signalling interactions during facial development. Mech. Dev. 75, 3-28.
19. Fukuda T., Yamagata K., Fujiyama S., Matsumoto T., Koshida I., Yoshimura K., Mihara M., Naitou M., Endoh H., Nakamura T., Akimoto C., Yamamoto Y., Katagiri T., Foulds C., Takezawa S., Kitagawa H., Takeyama K., O'Malley B.W. and Kato S. (2007). DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat. Cell. Biol. 9, 604-611.
20. Garcia A.M., Fletcher T., Benavides F.G. and Orts E. (1999). Parental agricultural work and selected congenital malformations. Am. J. Epidemiol. 149, 64-74.
21. Gorospe J.R., Naidu S., Johnson A.B., Puri V., Raymond G.V., Jenkins S.D., Pedersen R.C., Lewis D., Knowles P., Fernandez R., De Vivo D., van der Knapp M.S., Messing A., Brenner M. and Hoffman E.P. (2002). Molecular findings in symptomatic and pre-symptomatic Alexander disease patients. Neurology 58, 1494-1500.
22. Gowen L.C., Petersen D.N., Mansolf A.L., Qi H., Stock J.L., Tkalcevic G.T., Simmons H.A., Crawford D.T., Chidsey-Frink K.L., Ke H.Z., McNeish J.D. and Brown T.A. (2003). Targeted Disruption of the Osteoblast/Osteocyte Factor 45 Gene (OF45) Results in Increased Bone Formation and Bone Mass. J. Biol Chem. 278, 1998-2007.
23. Gritli-Linde A. (2007). Molecular control of secondary palate development. Dev. Biol. 301, 309-326.
24. Henningsen J., Rigbolt K.T., Blagoev B., Pedersen B.K. and Kratchmarova I. (2010). Dynamics of the skeletal muscle secretome during myoblast differentiation. Mol. Cell. Proteomics 9, 2482-2496.
25. Herring S.W. (1994). Development of functional interactions between skeletal and muscular systems. In: Bone: differentiation and morphogenesis of bone. Vol 9. Hall B.K. (ed). CRC. Boca Raton. Pp 165-191.
26. Höpken U.E., Lu B., Gerard N.P. and Gerard C. (1997). Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor. J. Exp. Med. 186, 749-756.
27. -/- embryos. Dev. Dyn. 233, 772-782.
28. Iseki S., Ishii-Suzuki M., Tsunekawa N., Yamada Y., Eto K. and Obata K. (2007). Experimental induction of palate shelf elevation in glutamate decarboxylase 67-deficient mice with cleft palate due to vertically oriented palatal shelf. Birth Defects Res. A Clin. Mol. Teratol. 79, 688-695.
29. Ito Y., Yeo J.Y., Chytil A., Han J., Bringas P. Jr, Nakajima A., Shuler C.F., Moses H.L. and Chai Y. (2003). Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects. Development 130, 5269-5280.
30. Jones D., Leivseth G. and Tenbosch J. (1995). Mechano-reception in osteoblast-like cells. Biochem. Cell Biol. 73, 525-534.
31. Jugessur A. and Murray J.C. (2005). Orofacial clefting: recent insights into a complex trait. Curr. Opin. Genet. Dev. 15, 270-278.
32. Juriloff D.M. and Harris M.J. (2008). Mouse genetic models of cleft lip with or without cleft palate. Birth Defects Res. A Clin. Mol. Teratol. 82, 63-77.
33. Kablar B. (2011). Role of skeletal musculature in the epigenetic shaping of organs, tissues and cell fate choices. In: Epigenetics: linking genotype and phenotype in development and evolution. Hallgrimsson B. and Hall B.K. (eds). University of California Press. pp 256-268.
34. Kablar B. and Rudnicki M.A. (2000). Skeletal muscle development in the mouse embryo. Histol. Histopathol. 15, 649-656.
35. Kahn M.L., Zheng Y.W., Huang W., Bigornia V., Zeng D., Moff S., Farese R.V. Jr, Tam C. and Coughlin S.R. (1998). A dual thrombin receptor system for platelet activation. Nature 394, 690-694.
36. Kaufman M.H. (1999). The atlas of mouse development. Revised edition. Academic Press. San Diego. pp 425-434.
37. Kavanagh E., Church V., Osborne A., Lamb K., Archer C., Francis-West P. and Pitsillides A. (2006). Differential regulation of GDF-5 and FGF-2/4 by immobilisation in ovo exposes distinct roles in joint formation. Dev. Dyn. 235, 826-834.
38. Kehler J., Tolkunova E., Koschorz B., Pesce M., Gentile L., Boiani M., Lomeli H., Nagy A., McLaughlin K.J., Scholer H.R. and Tomilin A. (2004). Oct4 is required for primordial germ cell survival. EMBO Rep. 5, 1078-1083.
39. Kishimoto T., Taga T. and Akirat S. (1994). Cytokine signal transduction. Cell 76, 253-262.
40. Koch P.J., de Viragh P.A., Scharer E., Bundman D., Longley M.A., Bickenbach J., Kawachi Y., Suga Y., Zhou Z., Huber M., Hohl D., Kartasova T., Jarnik M., Steven A.C. and Roop D.R. (2000). Lessons from loricrin-deficient mice. Compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J. Cell Biol. 151, 389-400.
41. Kudo T., Kaneko M., Iwasaki H., Togayachi A., Nishihara S., Abe K. and Narimatsu H. (2004). Normal embryonic and germ cell development in mice lacking alpha 1,3-fucosyltransferase IX (Fut9) which show disappearance of stage-specific embryonic antigen 1. Mol. Cell Biol. 24, 4221-4228.
42. Kusek J.C., Greene R.M., Nugent P. and Pisano M.M. (2000). Expression of the E2F family of transcription factors during murine development. Int. J. Dev. Biol. 44, 267-277.
43. Lammer E.J., Chen D.T., Hoar R.M., Agnish N.D., Benke P.J., Braun J.T., Curry C.J., Fernhoff P.M., Grix A.W. Jr and Lott I.T. (1985). Retinoic acid embryopathy. N. Engl. J. Med. 313, 837-841.
44. Li Y., Litingtung Y., Ten Dijke P. and Chiang C. (2007). Aberrant Bmp signaling and notochord delamination in the pathogenesis of esophageal atresia. Dev. Dyn. 236, 746-754.
45. Liedtke W., Edelmann W., Bieri P.L., Chiu F.C., Cowan N.J., Kucherlapati R. and Raine C.S. (1996). GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 17, 607-615.
46. Lindeman G.J., Dagnino L., Gaubatz S., Xu Y., Bronson R., Warren H.B. and Livingston D.M. (1998). A specific, non-proliferative role for E2F-5 revealed by gene targeting. Genes Dev. 12, 1092-1098.
47. Liou G.I., Fei Y., Peachey N.S., Matragoon S., Wei S., Blaner W.S., Wang Y., Liu C., Gottesman M.E. and Ripps H. (1998). Early onset photoreceptor abnormalities induced by targeted disruption of the interphotoreceptor retinoid-binding protein gene. J. Neurosci. 18, 4511-4520.
48. Loes S., Kettunen P., Kvinnsland I.H., Taniguchi M., Fujisawa H. and Luukko K. (2001). Expression of class 3 semaphorins and neuropilin receptors in the developing mouse tooth. Mech. Dev. 101, 191-194.
49. Loeys B.L., Chen J., Neptune E.R., Judge D.P., Podowski M., Holm T., Meyers J., Leitch C.C., Katsani N., Sharifi N., Xu F.L., Myers L.A., Spevak P.J., Cameron D.E., De Backer J., Hellemans J., Chen Y., Davis E.C., Webb C.L., Kress W., Coucke P., Rifkin D.B., De Paepe A.M. and Dietz H.C. (2005). A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 37, 275-281.
50. Luo G., Hofmann C., Bronckers A.L., Sohocki M., Bradley A. and Karsenty G. (1995). BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev. 9, 2808-2820.
51. Maller Schulman B.R., Liang X., Stahlhut C., DelConte C., Stefani G. and Slack F.J. (2008). The let-7 microRNA target gene, Mlin41/Trim71 is required for mouse embryonic survival and neural tube closure. Cell Cycle 15, 3935-3942.
52. Marazita M.L. (2002). Genetic etiologies of facial clefting. In: Understanding craniofacial anomalies. The etiopatho-genesis of craniosynostoses and facial clefting. Mooney M.P. and Siegel M.I. (eds). Wiley-Liss, New York. pp 147-161.
53. McPherron A.C., Lawler A.M. and Lee S.J. (1999). Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nat. Genet. 22, 260-264.
54. Miyajima A., Kitamura T., Harada N., Yokota T. and Arai K.-I. (1992). Cytokine receptors and signal transduction. Annu. Rev. Immunol. 10, 295-331.
55. Miyake A., Takahashi S., Nakamura Y., Inamura K., Matsumoto S., Mochizuki S. and Katou M. (2009). Disruption of the ether-a-go-go K+ channel gene BEC1/KCNH3 enhances cognitive function. J. Neurosci. 29, 14637-14645.
56. Nakashima M., Toyono T., Akamine A. and Joyner A. (1999). Expression of growth/differentiation factor 11, a new member of the BMP/TGF beta super family during mouse embryogenesis. Mech. Dev. 80, 185-189.
57. Oh W.-J., Westmoreland J.J., Summers R. and Condie B.G. (2010). Cleft Palate Is Caused by CNS Dysfunction in Gad1 and Viaat Knockout Mice. PLoS ONE 5, e9758.
58. Pearson O.M. and Lieberman D.E. (2004). The aging of Wolff's law. yearb. Phys. Anthropol. 47, 63-99.
59. Pedersen B.K. and Febbraio M.A. (2008). Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 88, 1379-1406.
60. Pitari G., Malergue F., Martin F., Philippe J.M., Massucci M.T., Chabret C., Maras B., Dupre S., Naquet P. and Galland F. (2000). Pantetheinase activity of membrane-bound vanin-1: lack of free cysteamine in tissues of vanin-1 deficient mice. FEBS Lett. 483, 149-154.
61. Rice R., Spencer-Dene B., Connor E.C., Gritli-Linde A., McMahon A.P., Dickson C., Thesleff I. and Rice D.P.C. (2004). Disruption of Fgf10/Fgfr2b-coordinated epithelial-mesenchymal interactions causes cleft palate. J. Clin. Invest. 113, 1692-1700.
62. Riley B.M., Mansilla M.A., Ma J., Daack-Hirsch S., Maher B.S., Raffensperger L.M., Russo E.T., Vieira A.R., Dode C., Mohammadi M., Marazita M.L. and Murray J.C. (2007). Impaired FGF signaling contributes to cleft lip and palate. Proc. Natl. Acad. Sci. USA 104, 4512-4517.
63. Rot I. and Kablar B. (2010). The influence of acoustic and static stimuli on development of inner ear sensory epithelia. Int. J. Dev. Neurosci. 28, 309-315.
64. -/- amyogenic fetuses reveal the importance of early contraction and static loading by striated muscle in mouse skeletogenesis. Dev. Genes Evol. 216, 1-9.
65. Rot-Nikcevic I., Downing K.J., Hall B.K. and Kablar B. (2007). Development of the mouse mandibles and clavicles in the absence of skeletal myogenesis. Histol. Histopathol. 22, 51-60.
66. Rubin J., Rubin C. and Jacobs C.R. (2006). Molecular pathways mediating mechanical signaling in bone. Gene 367, 1-16.
67. Rudnicki M.A. and Jaenisch R. (1995). The MyoD family of transcription factors and skeletal myogenesis. BioEssays 17, 203-209.
68. Rudnicki M.A., Schnegelsberg P.N., Stead R.H., Braun T., Arnold H.H. and Jaenisch R. (1993). MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75, 1351-1359.
69. Sadler T.W. and Langman J. (2005). Langman's essential medical embryology. Lippincott Williams & Wilkins. Philadelphia. p 96.
70. Sahay A., Molliver M.E., Ginty D.D. and Kolodkin A.L. (2003). Semaphorin 3F is critical for development of limbic system circuitry and is required in neurons for selective CNS axon guidance events. J. Neurosci. 23, 6671-6680.
71. Shou S., Scott V., Reed C., Hitzemann R. and Stadler H.S. (2005). Transcriptome analysis of the murine forelimb and hindlimb autopod. Dev. Dyn. 234, 74-89.
72. Slaney S.F., Oldridge M., Hurst J.A., Moriss-Kay G.M., Hall C.M., Poole M.D. and Wilkie A.O. (1996). Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome. Am. J. Hum. Genet. 58, 923-932.
73. Snyder-Warwick A.K., Perlyn C.A., Pan J., Yu K., Zhang L. and Ornitz D.M. (2010). Analysis of a gain-of-function FGFR2 Crouzon mutation provides evidence of loss of function activity in the etiology of cleft palate. Proc. Natl. Acad. Sci. USA 107, 2515-2520.
74. Solloway M.J. and Robertson E.J. (1999). Early embryonic lethality in Bmp5:Bmp7 double mutant mice suggests functional redundancy within the 60A subgroup. Development 126, 1753-68.
75. Szumska D., Pieles G., Essalmani R., Bilski M., Mesnard D., Kaur K., Franklyn A., El-Omari K., Jefferis J., Bentham J., Taylor J.M., Schneider J.E., Arnold S.J., Johnson P., Tymowska-Lalanne Z., Stammers D., Clarke K., Neubauer S., Morris A., Brown S.D., Shaw-Smith C., Cama A., Capra V., Ragoussis J., Constam D., Seidah N.G., Prat A. and Bhattacharya S. (2008). VACTERL/caudal regression/Currarino syndrome-like malformations in mice with mutation in the proprotein convertase Pcsk5. Genes Dev. 22, 1465-1477.
76. Taya Y., O'Kane S. and Ferguson M.W. (1999). Pathogenesis of cleft palate in TGF-beta3 knockout mice. Development 126, 3869-3879.
77. Tsunekawa N., Arata A. and Obata K. (2005). Development of spontaneous mouth/tongue movement and related neural activity, and their repression in fetal mice lacking glutamate decarboxylase 67. Eur. J. Neurosci. 21, 173-178.
78. Visel A., Thaller C. and Eichele G. (2004). GenePaint.org: an atlas of gene expression patterns in the mouse embryo. Nucleic Acids Res. 32, 552-556.
79. Wu H.H., Ivkovic S., Murray R.C., Jaramillo S., Lyons K.M., Johnson J.E. and Calof A.L. (2003). Autoregulation of Neurogenesis by GDF11. Neuron 37, 197-207.
80. Wurdak H., Ittner L.M., Lang K.S., Leveen P., Suter U., Fischer J.A., Karlsson S., Born W. and Sommer L. (2005). Inactivation of TGFbeta signaling in neural crest stem cells leads to multiple defects reminiscent of DiGeorge syndrome. Genes Dev. 19, 530-535.
81. Wyatt A.W., Osborne R.J., Stewart H. and Ragge N.K. (2010). Bone morphogenetic protein 7 (BMP7) mutations are associated with variable ocular, brain, ear, palate, and skeletal anomalies. Hum. Mutat. 31, 781-787.
82. Wyszynski D.F. and Beaty T.H. (1996). Review of the role of potential teratogens in the origin of human non-syndromic oral clefts. Teratology 53, 309-317.
83. Yang J.T., Rayburn H. and Hynes R.O. (1993). Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development 119, 1093-1105.
84. Zeng Y., Takada Y., Kjellstrom S., Hiriyanna K., Tanikawa A., Wawrousek E., Smaoui N., Caruso R., Bush R.A. and Sieving P.A. (2004). RS-1 gene delivery to an adult Rs1h knockout mouse model restores ERG b-wave with reversal of the electronegative waveform of X-linked retinoschisis. Invest. Ophthalmol. Vis. Sci. 45, 3279-3285.
85. Zouvelou V., Luder H.U., Mitsiadis T.A. and Graf D. (2009). Deletion of BMP7 affects the development of bones, teeth, and other ectodermal appendages of the orofacial complex. J. Exp. Zoolog. B Mol. Dev. Evol. 312, 361-374.